ArticleExpert opinion on therapeutic patents2010

Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840.

Heike WulffPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.